Metabolic control of lupus pathogenesis: central role for activation of the mechanistic target of rapamycin
Reference107 articles.
1. Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment;Perl;Autoimmunity,2010
2. The evolution of drug discovery in systemic lupus erythematosus;Wallace;Nat Rev Rheumatol,2015
3. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial;Merrill;Arth Rheum,2010
4. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial;Navarra;Lancet,2011
5. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4;Wofsy;J Exp Med,1985